Skip to main content
. Author manuscript; available in PMC: 2012 Nov 1.
Published in final edited form as: Biopharm Drug Dispos. 2011 Sep 22;32(8):471–481. doi: 10.1002/bdd.770

Table III.

Denosumab pharmacodynamic parameter estimates for serum/urine NTX in healthy postmenopausal women (PMW) and urine NTX in postmenopausal women with low bone mineral density, using integrated bone homeostasis model.

Parameter (units) Final Estimate CV%
Healthy PMW
DA (day−1) 9.55 17.7
Eb,sNTX (nM) 7.24 4.49
Eb,uNTX(nmol/mmolCr) 14.4 4.67
PMW with low BMD
DA (day−1) 9.55 a -
Eb,uNTX(nmol/mmolCr) 23.0 3.40
a

fixed parameter based on fitted biomarker (NTX) data in healthy PMW.